Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TECX

+ Watchlist+ Portfolio

Tectonic Therapeutic, Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$20.08
52-Week Range
$16.77 – $39.53
Market Cap
$411.32M
P/E (TTM)
—
EPS (TTM)
-4.63
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.83
PEG Ratio
—
Return on Equity
-35.46%
Return on Assets
-23.16%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
19.71
Debt/Equity
0.02
Total Debt
$3.92M
Free Cash Flow
$-45.45M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$188.96M

Market Snapshot

About

Tectonic Therapeutic, Inc. is a biotechnology company focused on developing novel therapeutics targeting G protein-coupled receptors (GPCRs). The company uses its proprietary GEODe platform to discover and develop medicines for diseases with significant unmet medical needs. Tectonic is advancing a pipeline of drug candidates in oncology, inflammation, and metabolic diseases.